Clinical Trial of the Treatment of Depressive Illness
Related Articles
- Commentary: Why stop at antidepressants? Hatcher, Simon // BMJ: British Medical Journal (International Edition);7/16/2005, Vol. 331 Issue 7509, p158
Offers a debate regarding the treatment of mental depression. Criticism of the approach to clinical trials of treatment for depression in which people with different severities of illness and symptoms are all included under the same heading of depression; Discussion of outcomes in depression trials.
- Recurrent unipolar depression requires prolonged treatment. Young, A. H. // British Journal of Psychiatry;Apr2001, Vol. 178, p294
The article discusses the study concerning the treatment of recurrent unipolar depression in Great Britain. Psychiatric disorder is recognized as one of the greatest causes of human suffering. Unipolar major depression imposes the second largest burden of any individual in the developed world....
- What's new in depression? Goldzband, Melvin G. // Cortlandt Forum;6/25/96, Vol. 9 Issue 6, p192
Presents a medical update related to the diagnosis and management of depression in the United States. Concept on the symptoms; Identification of clinical depression; Differential diagnosis of depression secondary to physical illness from primary depression; Treatment of depression manifested as...
- Trial of a sustained release form of amitriptyline (Lentizol) in the treatment of depressive illness. Sedman, G. // British Journal of Psychiatry;Jul73, Vol. 123 Issue 572, p69
The article presents a similar double blind cross-over trial in the treatment of depressive illness with the use of a new sustained release form of amitriptyline (Lentizol) , which can be given in a single dose for the treatment of depressive illness, compared against conventional amitriptyline...
- The facts about depression. // Public Management (00333611);Nov94, Vol. 76 Issue 11, p12
Describes the nature of depression as a treatable mental illness. Clinical definition of depression; Types of depression; Theories about the causes of the illness; Types of available treatment for those afflicted with.
- Lifting spirits. Spear, Linda // Westchester County Business Journal;06/12/2000, Vol. 39 Issue 24, p15
Discusses ways of managing clinical depression. Ranking of the disease in terms of morbidity and mortality; Effectiveness of psychotherapy and emerging medications in the treatment of depressed people; Symptoms of the illness; Diagnosis.
- Electroconvulsive therapy. Kendell, R. E. // Journal of the Royal Society of Medicine;May1978, Vol. 71 Issue 5, p319
The author reflects on the use of electroconvulsive therapy (ECT) in psychiatry. He remarks that ECT in psychiatry has been used in the treatment of severe depressive illness, but psychiatrist who use it are under attacked barely on accusations of its ineffectiveness, frightening and dangerous...
- Anterior Bifrontal ECT: A Clinical Trial. Abrams, Richard // British Journal of Psychiatry;Oct72, Vol. 121 Issue 563, p446
The article presents an abstract of the study "Anterior Bifrontal ECT: A Clinical Trial." The anterior bifrontal electroconvulsive therapy was suggested to minimize the memory loss of both dominant and non-dominant hemisphere dysfunction by keeping the direct effects of the electric current....
- Clinical evaluation of Kushmanda Ghrita in the management of depressive illness. Chandre, Rajni; Upadhyay, B. N.; Murthy, K. H. H. V. S. S. Narasimha // AYU: An International Quarterly Journal of Research in Ayurveda;Apr-Jun2011, Vol. 32 Issue 2, p230
Depressive illness has been considered as a problematic mental illness since antiquity. The treatment modalities of depressive illness are of many kinds. Use of Medhya Rasayana drugs is a unique method of treatment described in Ayurveda for depressive illness. Kushmanda (Benincasa hispida) is...
- Paroxetine Controlled Release: A Viewpoint by Mark H. Rapaport. Rapaport, Mark H. // CNS Drugs;2004, Vol. 18 Issue 6, p365
Comments on the controlled release of the antidepressant paroxetine in clinical trials. Pharmacokinetic profile of the drug; Efficacy of treating several mental illnesses and mental depression; Product safety.
